Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

benzinga.com/m-a/25/07/46296237/why-is-microcap-rallybio-stock-trading-higher-on-tuesday

Rallybio Corporation (NASDAQ:RLYB) agreed on Tuesday to sell its interest in REV102, an ENPP1 inhibitor in preclinical development for hypophosphatasia (HPP), to joint venture partner Recursion Pharmaceuticals Inc. (NASDAQ:RXRX).
The deal consideration of up to $25 million includes an…

This story appeared on benzinga.com, 2025-07-08 13:44:34.
The Entire Business World on a Single Page. Free to Use →